Clinical Trial Update: Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic, efficacy, and safety study comparing Octafibrin to Haemocomplettan/Riastap in congenital fibrinogen deficiency/afibrinogenemia has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Afibrinogenemia
• Congenital Fibrinogen Deficiency

Drugs mentioned

• Haemocomplettan/Riastap
• Octafibrin

Snippet

Sponsor: Octapharma | Conditions: Congenital Fibrinogen Deficiency, Afibrinogenemia | Phase 2 | Status: COMPLETED | Results posted: 2016-11-30